Precision BioSciences Inc...

NASDAQ: DTIL · Real-Time Price · USD
4.71
-0.06 (-1.26%)
At close: Aug 15, 2025, 3:59 PM
4.71
-0.11%
After-hours: Aug 15, 2025, 04:10 PM EDT

Precision BioSciences Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
68.7M 48.73M 25.1M 115.53M
Cost of Revenue
n/a 8.26M 9M n/a
Gross Profit
68.7M 40.47M 16.09M 115.53M
Operating Income
-26.16M -43.74M -100.37M -39.4M
Interest Income
6.76M 7.69M 3.47M 208K
Pretax Income
7.17M -42.53M -111.64M -30.6M
Net Income
7.17M -61.32M -122.91M -30.92M
Selling & General & Admin
35.3M 39.09M 41.52M 39.69M
Research & Development
59.56M 53.38M 83.94M 115.24M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
94.86M 92.46M 125.46M 154.93M
Interest Expense
1.78M 2.23M 1.11M 132K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
94.86M 92.46M 125.46M 154.93M
Income Tax Expense
n/a n/a 11.27M 316K
Shares Outstanding (Basic)
6.83M 3.84M 2.93M 1.96M
Shares Outstanding (Diluted)
6.88M 3.84M 2.93M 1.96M
EPS (Basic)
1.05 -15.96 -41.95 -15.8
EPS (Diluted)
1.04 -15.96 -41.95 -15.8
EBITDA
13.53M -32.04M -62.79M -20.27M
EBIT
8.95M -40.3M -71.8M -30.47M
Depreciation & Amortization
4.58M 8.26M 9M 10.2M